[Federal Register Volume 60, Number 73 (Monday, April 17, 1995)]
[Notices]
[Page 19264]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-9336]



[[Page 19264]]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Technical Advisory Committee for Diabetes Translation and 
Community Control Programs: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Technical Advisory Committee for Diabetes Translation and 
Community Control Programs.
    Times and Dates: 1 p.m.-5 p.m., Thursday, May 4, 1995. 8 a.m.-
11:30 a.m., Friday, May 5, 1995.
    Place: Adam's Mark Hotel, Vail Room, 1550 Court Place, Denver, 
Colorado 80202-5199, telephone 303/893-3333.
    Status: Open to the public, limited only by the space available.
    Purpose: This committee is charged with advising the Director, 
CDC, regarding priorities and feasible goals for translation 
activities and community control programs designed to reduce risk 
factors, morbidity, and mortality from diabetes and its 
complications. The committee advises regarding policies, strategies, 
goals and objectives, and priorities; identifies research advances 
and technologies ready for translation into widespread community 
practice; recommends public health strategies to be implemented 
through community interventions; advises on operational research and 
outcome evaluation methodologies; identifies research issues for 
further clinical investigation; and advises regarding the 
coordination of programs with Federal, voluntary, and private 
resources involved in the provision of services to people with 
diabetes.
    Matters To Be Discussed: Committee members will discuss progress 
towards a National Diabetes Education Program, evolving strategies 
and scientific activities related to screening for Type II diabetes, 
possible participation by CDC in the National Institutes of Health-
sponsored Diabetes Prevention Trial-Type II, policy and economic 
activities, and the status of mechanisms of CDC's Division of 
Diabetes Translation support to States.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Cheryl Shaw, Program 
Specialist, Division of Diabetes Translation, National Center for 
Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford 
Highway, NE, Mailstop K-10, Atlanta, Georgia 30341-3724, telephone 
404/488-5004.

    Dated: April 11, 1995.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 95-9336 Filed 4-14-95; 8:45 am]
BILLING CODE 4163-18-M